Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study.
about
Venlafaxine for neuropathic pain in adultsAntidepressants for neuropathic painRecommendations for the pharmacological management of neuropathic pain: an overview and literature updateEvidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and RehabilitatiPharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain SocietyNeuropathic cancer pain: What we are dealing with? How to manage it?Diabetic neuropathic pain: Physiopathology and treatmentRecommendations for the Management of Herpes ZosterAn integrated perspective on diabetic, alcoholic, and drug-induced neuropathy, etiology, and treatment in the US.Guidelines in the management of diabetic nerve pain: clinical utility of pregabalin.Treatment of diabetic sensory polyneuropathy.Diabetic neuropathy: mechanisms to managementTreating Diabetic Neuropathy: Present Strategies and Emerging Solutions.Painful diabetic neuropathy: advantage of novel drugs over old drugs?Clinical experience with desvenlafaxine in treatment of pain associated with diabetic peripheral neuropathyEvidence-based guideline: treatment of painful diabetic neuropathy--report of the American Association of Neuromuscular and Electrodiagnostic Medicine, the American Academy of Neurology, and the American Academy of Physical Medicine & RehabilitationCharacteristics of neuropathic pain in patients with spinal cord injury.Pharmacologic management of chronic pain.Bupropion for the treatment of neuropathic pain.Duloxetine withdrawal seizureDiabetic neuropathy: clinical manifestations and current treatments.An open-label, non-randomized comparison of venlafaxine and gabapentin as monotherapy or adjuvant therapy in the management of neuropathic pain in patients with peripheral neuropathyAntidepressants in the treatment of neuropathic pain.Combining opioid and adrenergic mechanisms for chronic pain.Treatment of painful diabetic neuropathyEFNS guidelines on pharmacological treatment of neuropathic pain.Therapeutic management of chronic neuropathic pain: an examination of pharmacologic treatment.Diabetic neuropathy: new strategies for treatment.Mechanisms and management of diabetic painful distal symmetrical polyneuropathy.Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society.The use of neuralgia medications to treat sensory neuropathic cough: our experience in a retrospective cohort of thirty-two patientsUpdate on the management of diabetic polyneuropathies.Pharmacological treatment of diabetic peripheral neuropathy.Alcoholic neuropathy: possible mechanisms and future treatment possibilitiesDuloxetine: pharmacoeconomic implications of an antidepressant that alleviates painful physical symptoms.Novel insights on diagnosis, cause and treatment of diabetic neuropathy: focus on painful diabetic neuropathyThe effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms.Amitriptyline 2% cream vs. capsaicin 0.75% cream in the treatment of painful diabetic neuropathy (Double blind, randomized clinical trial of efficacy and safety)The pharmacotherapy of chronic pain: a review.Evaluation of the efficacy and safety of pregabalin, venlafaxine, and carbamazepine in patients with painful diabetic peripheral neuropathy. A randomized, double-blind trial.
P2860
Q24187793-9D6DC4FB-B447-49D8-9844-57566C6DEAF5Q24243292-A8429649-8CC2-4EBB-8026-2445CB68D07DQ24616897-D58155F1-4AB9-4F49-9F9C-70CB2D03D723Q24632313-DBC8D988-E041-47A6-9372-ED64B3126A33Q24657295-49CF687A-73E0-419C-AB68-8E14A16F5698Q26998945-3587DB15-D20B-4503-89B1-5EEB23C61EABQ27004604-433F1A48-6968-4D11-A149-3FA0E442852CQ28315869-64F93575-710F-4D1B-8DDB-D7DBB7F4B718Q30236003-7A014FD3-8FF0-4ADD-97A1-7F657F4E7001Q30537158-57BBD48E-B31F-4F7A-B210-13DFF40C3ABBQ33393882-739D2ACF-23C9-4AFF-B3BC-856E72C0EF0EQ33554384-86AD5930-EABC-4E67-B552-9EC631228680Q33583006-E97109DE-72AB-482B-9B25-DE381F7C2B37Q33610824-E69B1044-8A5C-41EB-890A-5DDC0F5C4BCBQ33824509-1A8194B1-FD6A-47D4-8ED5-56B6C89BE1D6Q33870062-3DDF0CED-8D1F-47B5-91BB-C1BB6E07771BQ33882897-61F751BD-90C4-4302-B98D-A4C45ECE8806Q33915700-9747FF6A-CEDE-4A33-B72D-DCBFC0336CB1Q34100677-01272A5B-1869-420E-B3A2-24F9359E5809Q34237149-E7D50B04-9225-4260-B480-033FE2C817DBQ34275990-F1C4751A-F698-4AAB-AB70-882B77652E60Q34418375-C3DB5AD1-539E-4851-A7E2-A34114412C1BQ34420689-A4D49670-CD8E-47BA-8805-6B5422920485Q34434307-21B4A29B-29C9-437C-8644-94EB4D62EF87Q34456265-8ABFC62A-97C1-41DB-A509-85388CF387F6Q34573607-25AD10FB-9801-4197-B816-EAB114D5F18CQ34595383-59C9D986-40E2-4E48-B153-02B181335113Q34641965-3E22712C-60F5-4792-909F-E720C9F0F37BQ34655586-F4C8FF0D-A115-42AC-A207-234BA3FA965DQ34756198-BA8E2C0B-BD0C-4E71-ADCC-6E58D3C0525AQ35174037-B68D7724-EF82-450E-B30F-8BC60AD59585Q35178801-B5DC4428-D8D7-4BED-8C97-E0BF05C9C407Q35669997-8294050A-BBD1-499D-B2C3-FEAB576BD38DQ36017359-9605E0B9-DC4E-4F61-8ADE-3C1B6898F345Q36150758-827D37CE-5DCE-4F1D-8D80-D2796878D73EQ36329924-B414ECB0-926A-46EB-8938-BC54A8A3150AQ36349761-A35F038A-A320-47A5-8D05-EF06E3A86E3FQ36358428-8ECE8884-F7CB-4182-8212-99EA182AAD98Q36411163-2635184C-1DFF-4D6D-A17B-E9E31120D30EQ36504620-D5090EEB-0876-4E41-AE99-96BFC4778C91
P2860
Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study.
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Venlafaxine extended release i ...... ind, placebo-controlled study.
@ast
Venlafaxine extended release i ...... ind, placebo-controlled study.
@en
Venlafaxine extended release i ...... ind, placebo-controlled study.
@nl
type
label
Venlafaxine extended release i ...... ind, placebo-controlled study.
@ast
Venlafaxine extended release i ...... ind, placebo-controlled study.
@en
Venlafaxine extended release i ...... ind, placebo-controlled study.
@nl
prefLabel
Venlafaxine extended release i ...... ind, placebo-controlled study.
@ast
Venlafaxine extended release i ...... ind, placebo-controlled study.
@en
Venlafaxine extended release i ...... ind, placebo-controlled study.
@nl
P2093
P1433
P1476
Venlafaxine extended release i ...... ind, placebo-controlled study.
@en
P2093
Michael C Rowbotham
Nadia R Kunz
Veeraindar Goli
P304
P356
10.1016/J.PAIN.2004.05.010
P407
P577
2004-08-01T00:00:00Z